Literature DB >> 945301

Treatment of women with the galactorrhea-amenorrhea syndrome with pyridoxine (vitamin B6).

E N McIntosh.   

Abstract

Three women with the galactorrhea-amenorrhea syndrome and elevated prolactin concentrations experienced a return of regular ovulatory menses within 37-94 days after starting pyridoxine treatment (200-600 mg/day). In each the galactorrhea ceased and serum prolactin levels were maintained in the normal range while taking pyridoxine. In two other women with prolonged secondary amenorrhea but without hyperprolactinemia or galactorrhea, pyridoxine at dosages up to 600 mg/day did not restore ovulatory menses. Pyridoxine treatment was also ineffective in decreasing profuse galactorrhea in one woman with normal prolactin levels and regular ovulatory menses. In the three women effectively treated with pyridoxine, the galactorrhea returned, serum prolactin levels increased, and the menses ceased after discontinuing pyridoxine. These results imply that pyridoxine, by decreasing the excessive secretion of prolactin, may be useful in the long-term medical management of women with hyperprolactinemia and the galactorrhea-amenorrhea syndrome.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 945301     DOI: 10.1210/jcem-42-6-1192

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Effect of vitamin B6 on the serum concentration of pituitary hormones in normal humans and under pathologic conditions.

Authors:  M Bigazzi; S Ferraro; R Ronga; G Scarselli; V Bruni; A L Olivotti
Journal:  J Endocrinol Invest       Date:  1979 Apr-Jun       Impact factor: 4.256

Review 2.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

3.  Pharmacological treatment strategies for antipsychotic-induced hyperprolactinemia: a systematic review and network meta-analysis.

Authors:  Zhe Lu; Yaoyao Sun; Yuyanan Zhang; Yu Chen; Liangkun Guo; Yundan Liao; Zhewei Kang; Xiaoyang Feng; Weihua Yue
Journal:  Transl Psychiatry       Date:  2022-07-05       Impact factor: 7.989

Review 4.  Vitamin therapy in the absence of obvious deficiency. What is the evidence?

Authors:  L Ovesen
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

5.  Failure of pyridoxine to effect neuroleptic-induced hyperprolactinemia in psychotic patients.

Authors:  F Brambilla; G Penati; S Freni; S Bottinelli; C Maffei; V Maiella
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

6.  Effects of megadoses of pyridoxine on spermatogenesis and male reproductive organs in rats.

Authors:  K Mori; M Kaido; K Fujishiro; N Inoue; O Koide
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.